Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Preomics GmbH is currently navigating 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. This volume of 4 pending office actions suggests a robust and active prosecution strategy aimed at securing intellectual property in a highly competitive field. Within Biotechnology & Pharmaceuticals, managing multiple actions simultaneously requires careful coordination to ensure consistent arguments across the entire portfolio.
The company's applications are being reviewed by 4 distinct examiners across 4 distinct art units. This one-to-one ratio of 4 distinct examiners to 4 distinct art units indicates a high degree of technical specialization for each filing. Because the workload is spread across 4 distinct examiners, the company must adapt its response strategies to meet the specific requirements and preferences of several different patent office officials.
GIERE, REBECCA M is identified as the busiest examiner, with 1 pending office action currently under review. Since 1 pending office action is assigned to this examiner, the success of that specific filing depends on their interpretation of the prior art. The 4 pending office actions in the total portfolio are more than the 1 pending office action assigned to GIERE, REBECCA M.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GIERE, REBECCA M | 1 | 73.7% | +32.3% |
| FERNANDEZ, SUSAN EMILY | 1 | 52.3% | +60.9% |
| XU, XIAOYUN | 1 | 59.9% | +31.6% |
| BOWERS, NATHAN ANDREW | 1 | 59.5% | +31.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009649 | DISPERSION USING A MOVING MAGNET | GIERE, REBECCA M | 44d overdue |
| 17254841 | MEANS AND METHODS FOR LYSING BIOLOGICAL CELLS | BOWERS, NATHAN ANDREW | 21d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924113 | SAMPLE PREPARATION FOR MASS SPECTROMETRY | XU, XIAOYUN | 100d overdue |
| 18009649 | DISPERSION USING A MOVING MAGNET | GIERE, REBECCA M | 44d overdue |
| 17254841 | MEANS AND METHODS FOR LYSING BIOLOGICAL CELLS | BOWERS, NATHAN ANDREW | 21d |
| 17924950 | MAGNETIC CLEAVAGE OF COMPOUNDS | FERNANDEZ, SUSAN EMILY | — |
| Art Unit | Apps |
|---|---|
| 1677 | 1 |
| 1651 | 1 |
| 1797 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18009649 | DISPERSION USING A MOVING MAGNET | GIERE, REBECCA M | 1677 | §103§112 | Final Rejection | 44d overdue | Pending | Dec 09, 2022 |
| 17924950 | MAGNETIC CLEAVAGE OF COMPOUNDS | FERNANDEZ, SUSAN EMILY | 1651 | §103Other | Non-Final OA | — | Pending | Nov 11, 2022 |
| 17924113 | SAMPLE PREPARATION FOR MASS SPECTROMETRY | XU, XIAOYUN | 1797 | §103§112DP | Non-Final OA | 100d overdue | Pending | Nov 08, 2022 |
| 17254841 | MEANS AND METHODS FOR LYSING BIOLOGICAL CELLS | BOWERS, NATHAN ANDREW | 1799 | §103§112 | Final Rejection | 21d | Pending | Dec 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPreomics GmbH has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Rebecca M Giere has the most, with 1 of Preomics GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
